扶正消瘤汤对乳腺癌术后患者免疫功能和远期疗效的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R737.9

基金项目:


Effect of Fuzheng Xiaoliu Decoction on Immune Function and Long- term Curative Effect in Patients After Surgery of Breast Cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察扶正消瘤汤对乳腺癌术后患者免疫功能和远期疗效的影响。方法:将100 例乳腺癌术 后患者按随机数字表法分成观察组及对照组各50 例。2 组均根据2017 版中国抗癌协会乳腺癌诊治指南与规范 选择常规辅助化疗方案,观察组在化疗方案基础上加用扶正消瘤汤治疗。比较2 组优良率、转移率、局部复发 率,比较2 组治疗前后中医证候积分、血清肿瘤标志物水平及免疫功能指标水平。结果:观察组治疗总有效 率、转移率、局部复发率分别为92.00%、10.00%、8.00%,对照组治疗总有效率、转移率、局部复发率分别为 76.00%、28.00%、30.00%,观察组治疗总有效率高于对照组(P<0.05),转移率、局部复发率低于对照 组(P<0.05)。治疗前,2 组神疲乏力、失眠、口干、出汗、乳房胀痛中医证候积分比较,差异均无统计学意 义(P>0.05);治疗后,2 组神疲乏力、失眠、口干、出汗、乳房胀痛中医证候积分均下降(P<0.05),且观 察组低于对照组(P<0.05)。治疗前,2 组血清癌胚抗原(CEA)、糖类抗原125 (CA125)、糖类抗原 153 (CA153) 水平比较,差异无统计学意义(P>0.05);治疗后,2 组血清CEA、CA125、CA153 水平均下 降(P<0.05),且观察组低于对照组(P<0.05)。治疗前,2 组CD4+、CD8+、CD4+/CD8+、CD3+比较,差异无 统计学意义(P>0.05)。治疗后,观察组CD4+、CD4+/CD8+、CD3+均升高(P<0.05),CD8+降低(P<0.05); 对照组CD4+、CD4+/CD8+、CD3+均降低(P<0.05),CD8+升高(P<0.05);且观察组CD4+、CD4+/CD8+、CD3+ 均高于对照组(P<0.05),CD8+低于对照组(P<0.05)。结论:扶正消瘤汤结合常规辅助化疗治疗乳腺癌术后 患者远期疗效满意,可改善中医症状和免疫功能,降低肿瘤标志物水平。

    Abstract:

    Abstract: Objective: To observe the effect of Fuzheng Xiaoliu Decoction on immune function and long- term curative effect in patients after the surgery of breast cancer. Methods:A total of 100 cases of patients underwent the surgery of breast cancer were divided into the observation group and the control group according to the random number table method, with 50 cases in each group. Both groups were treated with routine adjuvant chemotherapy regimens according to the 2017 CACA Guidelines for Diagnosis and Treatment of Breast Cancer,and the observation group was additionally treated with Fuzheng Xiaoliu Decoction based on the chemotherapy regimens. The excellent and good rates,the metastasis rates,and the local recurrence rates in the two groups were compared between the two groups. Traditional Chinese medicine (TCM) syndrome scores and the levels of serum tumor markers and immune function indexes were compared before and after treatment between the two groups. Results: The total effective rate, metastasis rate and local recurrence rate in the observation group were 92.00% , 10.00% , and 8.00% respectively, and the total effective rate, metastasis rate and local recurrence rate in the control group were 76.00%,28.00%,and 30.00% respectively;the total effective rate in the observation group was higher than that in the control group (P<0.05), and metastasis rate and local recurrence rate in the observation group were lower than those in the control group (P<0.05). Before treatment,there was no significant difference being found in the comparison of TCM syndrome scores including fatigue and lack of strength,insomnia,dry mouth,sweating,and distending pain of the breasts between the two groups (P>0.05);after treatment,TCM syndrome scores including fatigue and lack of strength,insomnia,dry mouth, sweating, and distending pain of the breasts in the two groups were decreased (P<0.05), and the above scores in the observation groups were lower than those in the control group (P<0.05). Before treatment, there was no significant difference being found in the comparison of the levels of carcinoembryonic antigen (CEA), carbohydrate antigen 125 (CA125), and carbohydrate antigen 153 (CA153) in serum between the two groups (P>0.05); after treatment, the levels of CEA, CA125, and CA153 in serum in the two groups were decreased (P<0.05),and the three levels in the observation group were lower than those in the control group (P<0.05). Before treatment,there was no significant difference being found in the comparison of CD4+,CD8+,CD4+/CD8+,and CD3+ between the two groups (P>0.05). After treatment,CD4 +,CD4 +/CD8 +,and CD3 + in the observation group were increased (P<0.05),and CD8+ was decreased (P<0.05);CD4+,CD4+/CD8+,and CD3+ in the control group were decreased (P< 0.05),and CD8 + was increased (P<0.05);CD4 +,CD4 +/CD8 +,and CD3 + in the observation group were higher than those in the control group (P<0.05),and CD8 + was lower than that in the control group (P< 0.05). Conclusion: Fuzheng Xiaoliu Decoction combined with conventional adjuvant chemotherapy has a satisfactory long- term effect on patients with breast cancer after surgery, which can improve Chinese medicine symptoms and immune function and reduce the levels of tumor markers.

    参考文献
    相似文献
    引证文献
引用本文

付培亭,马利燕,张宇峰.扶正消瘤汤对乳腺癌术后患者免疫功能和远期疗效的影响[J].新中医,2023,55(11):164-168

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-06-16
  • 出版日期: